3[1]Rasmussen L, Oster JE, Qvist N, et al. The effects of omeprazole on intragastric pH, intestinal motility, and gastric emptying rate[J]. Scand J Gastroenterol，1999，34(7):671-675.
4[2]Fuchs KH, Fein M, Maroske T, et al. The role of 24-hr gastric pH monitoring in the interpretation of 24-hr gastric bile monitoring for duodenogastric reflux[J]. Hepatogastroenterology，1999，46(25):60-65.
5[3]Kromer W, Horbach S, Luhmann R. Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis[J]. Pharmacology，1999，59(2):55-77.
6[4]Hasselgren G, Keelan M, Kirdeikis P, et al. Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH-metry study with omeprazole[J]. Eur J Gastroenterol Hepatol，1998，10(7):601-606.
7[5]Savarino V, Mela GS, Zentilin P, et al. Comparison of 24-hr control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer[J]. Aliment Pharmacol Ther，1998，12(12):1241-1247.
8[6]Nishioka K, Nagao T, Urushidani T. Correlation between acid secretion and proton pump inhibitiors omeprazole and pantoprazole. Biochem Pharmacol，1999，58(8):1349-1359.
9Lew EA, Pisegna JR, Starr JA, et al. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger Ellison syndrome. Gastroenterology, 2000,118: 696-704.
10Metz DC. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion. Digestion, 2000,62:73-81.
